diagnosis
PNH Non-Transplant Therapies and Management -2023 Omaha Patient -Family Hybrid Conference
From the 2023 Omaha Patient and Family Hybrid Conference: PNH Non-Transplant Therapies with Dr. Alex Nester. Learn symptom management and options for therapies in this session which includes questions from the audience.
Afaf Osman, MD
Osman, Afaf
Hematologist/Oncologist
Huntsman Cancer Center, University of Utah
Online Profile:
Sagar S. Patel, MD
Patel, Sagar
Assistant Professor, Huntsman Cancer Institute
Huntsman Cancer Institute
Online Profile:
Prajwal Dhakal, MBBS
Dhakal, Prajwal
Medical Oncologist
University of Iowa Hospitals & Clinics
Online Profile:
Alex Nester, MD
Nester, Alex
Assistant Professor, Division of Oncology & Hematology
University of Nebraska Medical Center
Amanda Przespolewski, DO
Amanda, Przespolewski
Assistant Professor, Medical Oncology
Roswell Park Comprehensive Cancer Center
Online Profile:
Srinivas Tantravahi, MBBS, MRCP
Srinivas, Tantravahi
Hematologist
Huntsman Cancer Hospital
Dr. Tantravahi has received his medical degree from Guntur medical college, India. He then completed Internal Medicine residency and Hematology and Oncology fellowship training at University of Utah Hospital. His clinical interests include multiple myeloma, stem cell transplantation, and myeloproliferative neoplasm. Research interests are targeted therapy in CML and myeloproliferative neoplasms.
Online Profile:
2023 Omaha Patient and Family Hybrid Conference
Here are the session recordings and the presentations for the 2023 Omaha Patient and Family Hybrid Conference.
Event Date:
Sat, 04/15/2023 - 9:30am (EDT)
Conference Materials:
Bone Marrow Disease(s):
Conference Event Type:
Ask the AML Expert
Dr. Salman Fazal will gives a brief AML overview and then answers questions from participants. The question and answer session is recorded here.